Filing metadata

Accession number
0001209191-21-027684
Form type
Form 4
Filer
Outlook Therapeutics, Inc.
CIK
CIK 1649989
Filed
Apr 20, 2021
Reporting period
Apr 19, 2021
Description
Insider transaction

Explore SEC Filings Hub